Edwards Lifesciences Corporation Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $45.88B). The key difference: Edwards Lifesciences Corporation Common Stock and Vivmark Residential Common Shares of Beneficial Interest are close in size by market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.74% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | VMRK | |
|---|---|---|
Market Cap | $49.44B | $45.88B |
Volume | 3,508,027 | 4,028,975 |
Sector | Health | Real Estate |
52-Week High | $95.18 | $70.15 |
52-Week Low | $72.65 | $57.98 |
Enterprise Value | $45.90B | $54.98B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 4.74% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →